Follow Us:

social twitter box white 32 social facebook box blue 32social linkedin box blue 32ISN Blog

Wednesday, 03 June 2015 13:55

30th International Vicenza Course on Peritoneal Dialysis

By 
Rate this item
(0 votes)

vicenza course

 

30th International Vicenza Course on Peritoneal Dialysis

Opening Ceremony

  • Vicenzanephrocourses: Thirty years in three minutes - C. Ronco
  • Lazaro Gotloib Memorial Lecture: Past, present and future of PD - N. Lameire

Session 1: Summit on PD around the world

  • The International Society of Nephrology - G.Remuzzi
  • The European Renal Association ERA-EDTA - R. Vanholder
  • The EUROPD- A. Joerres
  • The International Society of Peritoneal Dialysis - I. Teitelbaum
  • The ISPD - Asian Chapter - K.S. Nayak
  • The American Society of Nephrology - J. Burkart
  • The Chinese Society of Nephrology - Z.H. Liu
  • The European Society of Pediatric Nephrology - E. Verrina
  • The Latin American Society of Nephrology - R. Correa-Rotter
  • The Italian Society of Nephrology - G. Capasso

Session 2: Research in Peritoneal Dialysis - the last and next thirty years

  • Peritoneal Membrane Morphology - G. Garosi
  • Peritoneal transport - B. Rippe
  • Peritoneal Membrane biology - O. Devuyst
  • Peritoneal Dialysis solutions - A. Joerres
  • Treatment modalities and targets - J. Burkart
  • PD in pts with abdominal and thoracic abnomalities - M. Misra

Session 3: Peritoneal Dialysis Solutions

  • Biocompatibility of PD solutions - R. Mehrotra
  • PD solutions and nutritional status - C.Verger
  • 20 years of bicarbonate solutions - M. Feriani
  • Alternative dialysis strategies with icodextrin - I. Teitelbaum
  • Are current solutions adequate for pediatric use? - E. Verrina

Session 4: New challenges for PD and home therapies

Session 4b: Practical Issues in Peritoneal Dialysis

 

  • The financial benefits of home therapies - R. Greenwood
  • When and how to start peritoneal dialysis - M. Schreiber
  • The Brazilian PD Study (BRAZPD) - J. Divino
  • Outcomes: PD vs HD - R. Mehrotra
  • Hypogonadism, wasting and ESA resistance - P. Stenvinkel

 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 

  • Getting the right patient on the right treatment - M. Perez Fontan
  • Barriers and opportunities of home therapies - N. Lameire
  • How to avoid technique failure in PD - J.P. Ryckelynck
  • Ultrafiltration failure: diagnosis & management - W. Van Biesen

Session 5: Telemedicine and e-Health on PD

  • Computer assisted Data Collection and management - C. Ronco
  • Telemedicine in peritoneal dialysis - M. Rosner
  • e-Health: remote health care models in PD - W. Van Biesen
  • Cardiovascular complications in PD patients - D.G Struijk
  • Remote monitoring of PD in special locations - K.S. Nayak

Session 6: Lipid disorders, inflammation and anemia

  • Dialysis option for the very elderly - M. Rosner
  • Anemia management in PD patients - F. Locatelli
  • Maximising EPO response: Iron strategies - K.S. Nayak
  • Lipid disorders in uremia & dialysis - G. Bakris
  • Statins and lipid lowering strategies in PD - O. Heimbürger 

Session 7: CKD-MBD and Inflammation Management in PD

  • Which phosphate binder in PD patients - M. Cozzolino
  • Use of VDR Activitations in PD - J. Bover
  • Calcimimetrics in PD patients - P. Messa
  • Factors affecting loss of residual functions in Dialysis - N. Levin
  • New therapeutic options for inflammation in PD - D. Warrock

Session 8: Fluid overload and cardiovascular

 

 

Session 8b: Practical Issues in Peritoneal Dialysis 2

  • Fluid homeostasis in PD - J. Teixodo
  • BIVA + BNP in PD patients - C. Crepaldi
  • PD in heart failure patients - M. Schreiber
  • Role of PD in Cardio-Renal patients - A. Rodrigues

 
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

  • PD access: what's the best approach? - M. Riella
  • Catheter placement techniques - W. Van Biesen
  • Infectious complications: treatment considerations - A Joerres
  • Adequacy in peritoneal dialysis - J.P. Ryckelynck
  • Setting up research in PD - J. Witowski

Session 9: Controversies

  • Do we need PD guidelines? Yes, They are useful - N. Lameire
  • Do we need PD guidelines? No, they are dangerous - R. Amerling
  • Take patients off PD after 7 years to prevent EPS? Yes, we must! - F. Finkelstein
  • Take patients off PD after 7 years to prevent EPS? No, there is no need - E. Brown

Session 10: Peritoneal Dialysis Technology

  • Wearable technology: where are we? - C. Ronco
  • Continuous Flow PD - R. Amerling
  • 1 day HD and 5 days PD: does it make sense?  - J. Burkart
  • Time between catheter insertion and use - I. Teitelbaum
  • PD membrane evaluation in clinical practice - R. Krediet

Session 11: Peritonitis and other clinical outcomes

  • Today's approaches to prevent peritonitis - B. Piraino
  • Transplant outcome and dialysis modality- I. Teitelbaum
  • Pancreas/Kidney transplant in PD patients - M. Schreiber
  • Early diagnosis of Peritonitis: the case of NGAL - F.K. Martino
  • Prognostic factors for peritonitis outcome - D.G. Struijk
  • How to improve the care of diabetic patient on PD - M. Misra
  • How to select among dialysis option - A. Mooney

Additional Info

  • Language: English
  • Contains Audio: Yes
  • Content Type: Presentations
  • Source: Other sources
  • Event: Other events
  • Year: 2015
  • Members Only: No
Read 2035 times Last modified on Friday, 21 August 2015 12:46
Ariane Brusselmans

Director Programs and Education, ISN

Global Operations Center

Rue des Fabriques 1
1000 Brussels, Belgium
Tel: +32 2 808 04 20
Fax: +32 2 808 4454
Email contact

               

Americas Operations Center

340 North Avenue 3rd Floor
Cranford, NJ 07016-2496, United States
Tel: +1 567 248 9703
Fax: +1 908 272 7101
Email contact